Sign In
Search Icon
Menu Icon

Biomedical Advanced Research and Development Authority

Save the Date!

BARDA Industry Day

Driving Innovation for Preparedness and Response


Event Overview

Project NextGen
BARDA Supports Development of Next-Generation Medical Countermeasures

BARDA, in collaboration with the National Institute of Allergy and Infectious Diseases, is supporting the development of next generation medical countermeasures, including vaccines and therapeutics, to protect Americans from public health security threats such as coronaviruses. 


Learn More

The Biomedical Advanced Research and Development Authority (BARDA) provides an integrated, systematic approach to the development of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies such as chemical, biological, radiological, and nuclear (CBRN) accidents, incidents and attacks; pandemic influenza (PI), and emerging infectious diseases (EID).

Together with its industry partners, BARDA promotes the advanced development of medical countermeasures to protect Americans and respond to 21st century health security threats.

Partnering with BARDA

Program Areas

Portfolios

Innovation and Partnerships

CARB-X Logo  
DRIVe Logo  
Blue Knight Logo  
BARDA Ventures Logo  
Culture of Innovation Logo  
 

Meet the Director

 

Dr. Gary Disbrow is the Director of the Biomedical Advanced Research and Development Authority (BARDA), a component of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services. Read More

Accomplishments

81
FDA approvals, licensures, and clearances

Enhancing the nation's preparedness by partnering with innovators to make countermeasures available.

Learn More »

128
Biomedical products supported for COVID-19 response

Responding to the COVID-19 pandemic by developing vaccines, therapeutics, and diagnostics to help fight the virus.

Learn More »

1,390+
BARDA-supported COVID-19 Partnerships

COVID-19 CoronaWatch Virtual Market Research Meetings with innovative companies.

Learn More »